Approximately 80% of children three years of age and younger are affected by otitis media, with treatment costs estimated at more than $5 billion per year.
![](https://www.enttoday.org/wp-content/uploads/springboard/image/2007_08_07.gif)
Approximately 80% of children three years of age and younger are affected by otitis media, with treatment costs estimated at more than $5 billion per year.
The remarkable new tools of the genomic generation have been used by researchers at the House Ear Institute in Los Angeles, Translational Genomics Research Institute in Phoenix, and the University of Antwerp, Belgium, to zero in on genes that cause presbycusis, or age-related hearing loss.
The prevalence of biofilms was discussed in several presentations at the Combined Otolaryngology Spring Meetings here.
ENToday recently reported on a move toward more conservative use of antibiotics and ventilation tubes in the treatment of pediatric ear infections.
Sudden sensorineural hearing loss (SSHL) has stumped otolaryngologists for decades.
An estimated 31 million Americans are affected by some level of hearing loss and, as the population ages, that number will continue to rise.
Elderly patients have multiple reasons for losing their balance. Muscles are weaker, spines start to twist, bones may become brittle.
After a hiatus associated with a checkered past, gene therapy is again showing promise in several fields of medicine, and otolaryngology is no exception.